New hope for kids with tough leukemia: donor cell therapy trial opens
NCT ID NCT06080191
Summary
This early-stage trial is testing a new type of cell therapy for children and young adults whose B-cell leukemia has come back or hasn't responded to other treatments. Doctors are using immune cells from a donor, engineered to target the cancer, to see if this approach is safe and to find the best dose. The main goal is to understand the side effects and see if this therapy can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale Pediatrico Bambino Gesù
RECRUITINGRome, Italy, 00165, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.